RE:Only wierdos copy and paste the same article over & over Aussy, you did a very good anslyse. I would add, however, the potential for three lawsuits highly detrimental to Liminal. 1- Prosecution of damage and oppression of several hundred million by the shareholders before recapitalization. 2- Prosecution for repossession of license for non-compliance by Liminal with its development and marketing obligations. 3- Prosecution by patients who participated in clinical trials (Ryplazim) and no longer have access to the product contrary to the promises made by Prometic